CVE-2018-5237

Description

Symantec Endpoint Protection prior to 14 RU1 MP1 or 12.1 RU6 MP10 could be susceptible to a privilege escalation vulnerability, which is a type of issue that allows a user to gain elevated access to resources that are normally protected at lower access levels.

8.8

CVSS

Severity: High

CVSS 3.0 •

CVSS 2.0 •

EPSS 1.81% Top 20%

Vendor Advisory symantec.com

Affected: Symantec Corporation Symantec Endpoint Protection

References

Link	Tags
http://www.securityfocus.com/bid/104199	vdb entry third party advisory
http://www.securitytracker.com/id/1041180	vdb entry third party advisory
https://support.symantec.com/en_US/article.SYMSA1454.html	vendor advisory

Frequently Asked Questions

What is the severity of CVE-2018-5237?: CVE-2018-5237 has been scored as a high severity vulnerability.
How to fix CVE-2018-5237?: To fix CVE-2018-5237, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-5237 being actively exploited in the wild?: It is possible that CVE-2018-5237 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-5237?: CVE-2018-5237 affects Symantec Corporation Symantec Endpoint Protection.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.